Follow-The-Filings

Holders · period archive

STOK · Stoke Therapeutics Inc.

Q2 2024 13F holders among managers we track latest ownership dossier

Ticker
STOK
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares